Newcastle pharmacy experts work with Italian biotech lab to provide access to sight-saving treatment across England
Holostem and Chiesi Announce FDA Orphan Drug Designation for GPLSCD01 for treatment of Limbal Stem Cell Deficiency (LSCD)
